Literature DB >> 7672835

Serum adenosine deaminase, 5'-nucleotidase & alkaline phosphatase in breast cancer patients.

M Walia1, M Mahajan, K Singh.   

Abstract

Serum levels of adenosine deaminase (ADA), 5-nucleotidase (5'-NT) and alkaline phosphatase (ALP) were studied in 25 patients of carcinoma breast and 25 normal subjects. Adenosine deaminase was found to be the better probable parameter for the detection of cancer and to assess the development of various stages of cancer whereas 5'-nucleotidase had only diagnostic significance. Serum alkaline phosphatase levels were important for assessing the spread of cancer at secondary sites. After mastectomy a significant decrease was found in the levels of serum ADA and 5'-NT whereas no variations were found in case of serum ALP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672835

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  3 in total

1.  Elevated adenosine deaminase levels in celiac disease.

Authors:  Basak Cakal; Yavuz Beyazit; Seyfettin Koklu; Erdem Akbal; Ibrahim Biyikoglu; Gulsen Yilmaz
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Oxidative stress and its relationship with adenosine deaminase activity in various stages of breast cancer.

Authors:  Mridula Mahajan; Nitika Tiwari; Ritu Sharma; Sukhraj Kaur; Neetirajan Singh
Journal:  Indian J Clin Biochem       Date:  2012-08-17

3.  Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.

Authors:  Barbara Kutryb-Zajac; Patrycja Koszalka; Paulina Mierzejewska; Alicja Bulinska; Magdalena A Zabielska; Karolina Brodzik; Aleksandra Skrzypkowska; Lukasz Zelazek; Iwona Pelikant-Malecka; Ewa M Slominska; Ryszard T Smolenski
Journal:  J Cell Mol Med       Date:  2018-10-05       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.